Moderna Stock Issuance Proceeds increased by 18.8% to $19.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 533.3%, from $3.00M to $19.00M.
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Standard for large-cap companies with significant equity-based compensation programs.
proceeds_from_stock_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $12.00M | $17.00M | $11.00M | -$40.00M | $9.00M | $16.00M | $6.00M | $15.00M | $15.00M | $32.00M | $8.00M | $11.00M | $3.00M | $14.00M | $2.00M | $16.00M | $19.00M |
| QoQ Change | — | — | — | — | +41.7% | -35.3% | -463.6% | +122.5% | +77.8% | -62.5% | +150.0% | +0.0% | +113.3% | -75.0% | +37.5% | -72.7% | +366.7% | -85.7% | +700.0% | +18.8% |
| YoY Change | — | — | — | — | — | — | — | -25.0% | -5.9% | -45.5% | +137.5% | +66.7% | +100.0% | +33.3% | -26.7% | -80.0% | -56.3% | -75.0% | +45.5% | +533.3% |